# Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS

> **NCT05214963** · NA · COMPLETED · sponsor: **Noctrix Health, Inc.** · enrollment: 58 (actual)

## Conditions studied

- Restless Legs Syndrome

## Interventions

- **DEVICE:** NTX100 Neuromodulation System - Active
- **DEVICE:** NTX100 Neuromodulation System - Sham

## Key facts

- **NCT ID:** NCT05214963
- **Lead sponsor:** Noctrix Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-08
- **Primary completion:** 2023-07-24
- **Final completion:** 2023-10-24
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-12-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05214963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05214963, "Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05214963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*